» Articles » PMID: 11805322

Activation and Inhibition of G Protein-coupled Receptors by Cell-penetrating Membrane-tethered Peptides

Overview
Specialty Science
Date 2002 Jan 24
PMID 11805322
Citations 117
Authors
Affiliations
Soon will be listed here.
Abstract

Classical ligands bind to the extracellular surface of their cognate receptors and activate signaling pathways without crossing the plasma membrane barrier. We selectively targeted the intracellular receptor-G protein interface by using cell-penetrating membrane-tethered peptides. Attachment of a palmitate group to peptides derived from the third intracellular loop of protease-activated receptors-1 and -2 and melanocortin-4 receptors yields agonists and/or antagonists of receptor-G protein signaling. These lipidated peptides--which we have termed pepducins--require the presence of their cognate receptor for activity and are highly selective for receptor type. Mutational analysis of both intact receptor and pepducins demonstrates that the cell-penetrating agonists do not activate G proteins by the same mechanism as the intact receptor third intracellular loop but instead require the C-tail of the receptor. Construction of such peptide-lipid conjugates constitutes a new molecular strategy for the development of therapeutics targeted to the receptor-effector interface.

Citing Articles

Design and synthesis of cyclic lipidated peptides derived from the C-terminus of Cx43 for hemichannel inhibition and cardiac endothelium targeting.

Iaculli D, Montgomery J, Lamouroux A, Caufriez A, Gozalbes R, Vinken M RSC Med Chem. 2025; .

PMID: 39829973 PMC: 11740094. DOI: 10.1039/d4md00850b.


Exploring the Chemical Features and Biomedical Relevance of Cell-Penetrating Peptides.

Moreno-Vargas L, Prada-Gracia D Int J Mol Sci. 2025; 26(1.

PMID: 39795918 PMC: 11720145. DOI: 10.3390/ijms26010059.


Cancer-Targeting Applications of Cell-Penetrating Peptides.

Moreno-Vargas L, Prada-Gracia D Int J Mol Sci. 2025; 26(1.

PMID: 39795861 PMC: 11720565. DOI: 10.3390/ijms26010002.


Identifying and Assessing Putative Allosteric Sites and Modulators for CXCR4 Predicted through Network Modeling and Site Identification by Ligand Competitive Saturation.

Inan T, Flinko R, Lewis G, MacKerell Jr A, Kurkcuoglu O J Phys Chem B. 2024; 128(21):5157-5174.

PMID: 38647430 PMC: 11139592. DOI: 10.1021/acs.jpcb.4c00925.


Aiming the magic bullet: targeted delivery of imaging and therapeutic agents to solid tumors by pHLIP peptides.

Reshetnyak Y, Andreev O, Engelman D Front Pharmacol. 2024; 15:1355893.

PMID: 38545547 PMC: 10965573. DOI: 10.3389/fphar.2024.1355893.


References
1.
Wikstrom P, KIRSCHKE H, Stone S, Shaw E . The properties of peptidyl diazoethanes and chloroethanes as protease inactivators. Arch Biochem Biophys. 1989; 270(1):286-93. DOI: 10.1016/0003-9861(89)90030-1. View

2.
Gether U, Kobilka B . G protein-coupled receptors. II. Mechanism of agonist activation. J Biol Chem. 1998; 273(29):17979-82. DOI: 10.1074/jbc.273.29.17979. View

3.
Kjelsberg M, Cotecchia S, Ostrowski J, Caron M, Lefkowitz R . Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. J Biol Chem. 1992; 267(3):1430-3. View

4.
Schwarze S, Ho A, Dowdy S . In vivo protein transduction: delivery of a biologically active protein into the mouse. Science. 1999; 285(5433):1569-72. DOI: 10.1126/science.285.5433.1569. View

5.
Swift S, Sheridan P, Covic L, Kuliopulos A . PAR1 thrombin receptor-G protein interactions. Separation of binding and coupling determinants in the galpha subunit. J Biol Chem. 2000; 275(4):2627-35. DOI: 10.1074/jbc.275.4.2627. View